Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1015 results for "pharma trading company"

Wockhardt shares slump over 6% on recall of some drugs
DNA India

Wockhardt slumps on drug recall

The stock of drug maker Wockhardt Pharma has lost over 21 per cent in the last two trading sessions. The company's decision to recall some batches of drugs which were manufactured at its facilities Chikalthana and Waluj (Maharashtra), prior to the ... Hindu Business Line, 1 week ago
Wockhardt shares tank over 11% on recall of some drugs Daily Excelsior.com, 1 week ago

Sensex drops as banks, pharma majors decline

Indian stocks dropped for a third day this week in volatile trading, amid concern that company earnings will lag analyst estimates.State Bank of India fell for a second day and HDFC Bank, the most valuable lender, pared gains of as much as 1.3 per ...
 Business Standard1 week ago

Aerie Pharma plunges aftermarket as Rhopressa study fails

Shares of Aerie Pharmaceuticals lost two-thirds of their value in after-market trading after the company said its experimental eye pressure drug Rhopressa failed in a late-stage clinical trial. Aerie
 Yahoo! UK and Ireland1 week ago

IIROC Trading Halt - MJN

/CNW/ - The following issues have been halted by IIROC: Company: PharmaCan Capital Corp. TSX-Venture Symbol: MJN Reason: At the Request of the Company Pending News Halt Time (ET): 11:24 AM IIROC can make a decision to impose a ...
 Marketplace1 week ago IIROC Trading Halt - SLV  Yahoo! Finance1 week ago PharmaCan Capital : IIROC Trading Resumption - MJN  4 Traders1 week ago PHARMACAN CAPITAL : IIROC Trading Halt - MJN  4 Traders1 week ago
[x]  

Glenmark gets tentative USFDA nod for generic psoriasis cream

It said in a statement that Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Calcipotriene cream, 0.005 percent. The product is the therapeutic ...
 Jagran Post1 day ago Glenmark Pharma gets USFDA nod for oral contraceptives  The Financial Chronicle3 weeks ago
DNA

BSE gains over 100 points as markets regain some ground

Sun Pharma, which lost over 10% of its value on Tuesday after Daiichi Sankyo announced exiting the company by selling all its shares, gained over 2% on the NSE in morning trade.
 DNA1 week ago Sun Pharma: long-term portfolio therapy  Hindu Business Line1 week ago Japan's Daiichi Sankyo completely exits Sun Pharma  Jagran Post2 weeks ago Daiichi exits Sun; shares slump 9 per cent  Asian Age2 weeks ago
[x]  
Oneindia

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Drug major Sun Pharmaceutical today said its promoter and Managing Director Dilip Shanghvi did not buy shares of the company sold by the Japanese drugmaker Daiichi Sankyo. "...Dilip Shanghvi has neither purchased nor agreed to purchase any shares of our ...
 The Financial Chronicle1 week ago Shanghvi did not buy Daiichi shares, clarifies Sun Pharma  Economic Times1 week ago Sun Pharma Says Shanghvi Did Not Buy Shares From Daiichi Sankyo  Oneindia1 week ago Dilip Shanghvi Did Not Buy Daiichi Sankyo's Shares: Sun Pharma  Outlook India1 week ago
[x]  

Sun Pharma gains on getting USFDA's nod for Oxymorphone Hydrochloride

Sun Pharmaceutical Industries is currently trading at Rs 940.75, up by 1.50 points or 0.16% from its previous closing of Rs 939.25 on the BSE. The scrip opened at Rs. 930.00 and has touched a high and low of Rs. 943.90 and Rs. 921.90 respectively.
 Arihant Capital5 days ago Lupin trades with traction on BSE  Arihant Capital5 days ago Sun Pharma trades in pink of its health on BSE  Arihant Capital1 week ago

US states propose laws to force pharma companies reveal drug development cost

NEW DELHI: Just like the Supreme Court of India demanded that Bayer submit an account of its costs in developing the anti-cancer drug sorafenib, more and more states in the US are proposing legislations that could force pharmaceutical companies to ...
 Times of India6 days ago

Commerce ministry to talk to industry bodies to take a call on joining pharma regulator PICS

HYDERABAD: Small and medium-sized pharmaceutical companies are wary ahead of a meeting called by the government to decide whether India should become part of a multinational regulatory regime. Stricter standards, many fear, could drive up costs and ...
 Economic Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less